Summary

This article presents data from a multicenter study to compare outcomes of different formulations of estrogenic hormonal treatments in menopausal women. Results of the trial demonstrated a null effect on cardiovascular disease progression in association with hormone treatment, as well as a reduction in menopausal symptoms, and maintenance of bone mineral density.